Comparative effects of three naturally occurring furanocoumarins on mitochondrial bioenergetics.
Oxygraphic measurements of the rates of mitochondrial respiration in the presence of varying amounts of chalepin, imperatorin and marmesin, three naturally occurring furanocoumarins, revealed that the oxidation of NAD(+)-linked substrates was inhibited by chalepin and imperatorin and less significantly by marmesin. The order of potency being rotenone much greater than chalepin imperatorin greater than marmesin. There was no effect whatsoever on succinate oxidation by the furanocoumarins tested (up to 60 microM). State 3 respiration was also inhibited by these furanocoumarins; by at least 80% by 10 microM chalepin and by 48 and 29% with 60 microM imperatorin and 60 microM marmesin, respectively. Consequently, ADP control of respiration was diminished by those concentrations of furanocoumarins that inhibited respiration. At 60 microM, respiratory control ratio was reduced by about 88, 49 and 28% with chalepin, imperatorin and marmesin, respectively. A measurement of the rate of proton and Ca2(+)-movements across the mitochondrial coupling membrane demonstrated that succinate-supported transport was not affected by these furanocoumarins. On the other hand, pyruvate/malate-supported proton ejection was significantly inhibited by chalepin, imperatorin and marmesin. The order of the degree of inhibition of proton flux is rotenone much greater than chalepin greater than imperatorin greater than marmesin. The pattern of the inhibition of pyruvate/malate-supported Ca2(+)-transport was identical to that seen during proton transport. A comparison of the effects of chalepin to that of rotenone suggests that chalepin might be about 10 times less potent than rotenone.
Olorunsogo
O O
OO
Department of Biochemistry, College of Medicine, University of Ibadan, Nigeria.
Uwaifo
A O
AO
Malomo
S O
SO
D000818:Animals; D001692:Biological Transport; D002118:Calcium / Q000378:metabolism; D003374:Coumarins / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects*; D011564:Furocoumarins / Q000494:pharmacology; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism; D011522:Protons; D051381:Rats; D012402:Rotenone / Q000494:pharmacology; D013386:Succinates / Q000378:metabolism; D014812:Vitamin K / Q000494:pharmacology
D003374:Coumarins; D011564:Furocoumarins; D011522:Protons; D013386:Succinates; D012402:Rotenone; D009243:NAD; D014812:Vitamin K; C031533:chalepin; C001684:marmesin; C031534:imperatorin; D010100:Oxygen; D002118:Calcium